BioCentury
ARTICLE | Company News

Alza licenses compound from PPD

December 18, 2000 8:00 AM UTC

PPDI subsidiary PPD GenuPro granted AZA exclusive worldwide rights to develop and market dapoxetine selective serotonin reuptake inhibitor for genitourinary therapies, including premature ejaculation....